Tyra Biosciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for TYRA, updated each market day.
TYRA AI Sentiment
AI predicts Tyra Biosciences, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Tyra Biosciences, Inc. Common Stock
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Sector
Exchange
Market Cap
$1,976,384,449
Cap Tier
Employees
87
Headquarters
CARLSBAD, CA
Listed Since
Sept. 15, 2021
Website
TYRA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TYRA Volatility
Tyra Biosciences, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
